Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents

NCT04523246 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
217
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Oklahoma

Collaborators